WHO recommends antibody treatment for critical Covid patients

The WHO Guideline Development Group (GDG) panel recommends treatment combining casirivimab and imdevimab for two specific groups of patients with COVID-19.

from Latest News https://ift.tt/3o7NT6H
https://ift.tt/eA8V8J https://ift.tt/2LUVdkd

• Tweet
• Share
• Share
• Share
• Share